Pancreatic diseases due to the special anatomical structure of the pancreas itself and the complexity of physiological functions, which makes the research of pancreatic tumors slower than that of other abdominal tumors. The minimally invasive treatment of pancreatic tumors was carried out as early as in the 1960s, when laparoscopy was used in the diagnosis and treatment of pancreatic tumors. With the continuous development and optimization of laparoscopic instruments, its use in the field of surgery has become more and more widespread, but it is also the limitation of laparoscopic instruments, which can only be fixed at a certain angle, and thus it is difficult to perform operations such as suturing under laparoscopy. Peng Chenghong, Department of General Surgery, Shanghai Ruijin Hospital With the emergence of da Vinci robotic surgical system in recent years, there are obvious advantages in minimally invasive surgery, especially in minimally invasive pancreatic tumor treatment, the most important points are as follows: 1, the field of view during the operation is a three-dimensional image, with a visual depth of field; 2, the operating arm can be matched with the surgical instruments that have 7 degrees of freedom, which greatly improves the flexibility of the operation; 3, the field of operation is enlarged, which makes the operation more delicate, and for the operation, the operation is more flexible. The operation field is enlarged, which makes the operation more delicate, and the blood vessels and nerves can be observed more carefully; 4. The operation is the same as the open surgery, and the incision of the patient is significantly smaller after the operation. Since October 2010, our center has performed more than 500 robotic pancreatic surgeries, including more than 150 robotic pancreaticoduodenectomies. The volume of robotic pancreatic surgeries is currently ranked first in China and second in the world.